Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a time-sensitive operating status notice and funding-related disclaimer, and updated the version to v3.2.0 (removing v3.1.0).
    Difference
    1%
    Check dated 2025-10-03T08:50:29.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page updated to v3.1.0 and removed several MedlinePlus drug-safety topics (Drug Safety, Substandard Drugs, Counterfeit Drugs), signaling a reorientation or narrowing of content rather than new information.
    Difference
    0.3%
    Check dated 2025-09-26T04:24:47.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    - The only change is the deletion of the 'Back to Top' link; no core content, pricing, or time-sensitive information appears to be added or removed.
    Difference
    0.0%
    Check dated 2025-09-18T21:39:04.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Version bump: updated from v3.0.0-post.1-g752effb-HEAD to v3.0.2; no other content changed.
    Difference
    0.0%
    Check dated 2025-09-11T16:47:18.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated to a new version, v3.0.0-post.1-g752effb-HEAD, indicating a revision in the content. The 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-04T13:51:37.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous locations and facility names across various countries, as well as the inclusion of new medical topics related to drug safety and renal cell carcinoma. Notably, the previous version's references to certain locations and medical resources have been removed.
    Difference
    16%
    Check dated 2025-08-28T10:13:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.